Theravance Biopharma, Inc.

TBPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001583107

SEC filings (opens in a new tab)

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Theravance Biopharma, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of TBPH: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Of which not filed for Q2 2025	Q2 2025	Change
Holders	132	1	135	+4
Shares	44.9M	42	46.4M	+1.54M (+3.4%)
Value	$400.9M	$375	$512.2M	+$111.3M (+27.8%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Theravance Biopharma, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to TBPH in Q2 2025
Institution	Shares	Value	% of portfolio
Capitolis Liquid Global Markets LLC	127,200	$1.40M	0.01%
Jump Financial, LLC	79,074	$872.2K	0.01%
HSBC Holdings PLC	57,214	$637.9K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	56,613	$624.4K	0.00%
Militia Capital Partners, LP	54,200	$597.8K	0.28%
Campbell & CO Investment Adviser LLC	50,392	$555.8K	0.04%
Y-Intercept (Hong Kong) Ltd	40,943	$451.6K	0.01%
Walleye Capital LLC	34,659	$382.3K	0.00%
Rangeley Capital, LLC	33,729	$372.0K	0.47%
EntryPoint Capital, LLC	27,904	$307.8K	0.15%
Assenagon Asset Management S.A.	23,980	$264.5K	0.00%
Los Angeles Capital Management LLC	19,850	$218.9K	0.00%
Two Sigma Investments, LP	17,792	$196.2K	0.00%
Oxford Asset Management LLP	14,429	$159.2K	0.05%
Engineers Gate Manager LP	13,657	$150.6K	0.00%
Point72 Asset Management, L.P.	12,692	$140.0K	0.00%
Creative Planning	12,608	$139.1K	0.00%
Private Advisor Group, LLC	10,100	$111.4K	0.00%
Raymond James Financial Inc	692	$7.63K	0.00%
Global Retirement Partners, LLC	300	$3.31K	0.00%
Jones Financial Companies LLLP	85	$954	0.00%
Assetmark, Inc	51	$563	0.00%
Massmutual Trust Co FSB	33	$364	0.00%
CIBC Private Wealth Group, LLC	23	$254	0.00%

Sold out (20)

Institutions that held Theravance Biopharma, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of TBPH in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Arrowstreet Capital, Limited Partnership	221,469	$1.98M
Ameriprise Financial Inc	63,731	$569.1K
ExodusPoint Capital Management, LP	28,437	$254.0K
Magnetar Financial LLC	26,739	$238.8K
Corton Capital Inc.	22,243	$198.6K
SG Americas Securities, LLC	21,557	$193.0K
Public Employees Retirement System of Ohio	20,556	$183.6K
XTX Topco Ltd	19,759	$176.4K
Corebridge Financial, Inc.	18,219	$162.7K
TownSquare Capital, LLC	17,340	$154.8K
Verition Fund Management LLC	14,647	$130.8K
ProShare Advisors LLC	10,266	$91.7K
Prudential Financial Inc	10,140	$90.5K
Point72 (DIFC) Ltd	2,839	$25.4K
Coldstream Capital Management Inc	2,346	$21.0K
Point72 Hong Kong Ltd	400	$3.57K
Quadrant Capital Group LLC	335	$2.99K
Smartleaf Asset Management LLC	53	$489
CoreCap Advisors, LLC	27	$241
True Wealth Design, LLC	3	$27

Not filed for Q2 2025 yet (1)

Institutions that held Theravance Biopharma, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TBPH in Q1 2025 that haven't filed for Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Nova Wealth Management, Inc.	42	$375